Total Payments
$434,285
2024 Payments
$29,144
Companies
27
Transactions
593
Medicare Patients
7,315
Medicare Billing
$672,417
Payment Breakdown by Category
Other$380,115 (87.5%)
Consulting$28,948 (6.7%)
Food & Beverage$15,122 (3.5%)
Travel$10,069 (2.3%)
Education$30.66 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $378,583 | 205 | 87.2% |
| Consulting Fee | $28,948 | 16 | 6.7% |
| Food and Beverage | $15,122 | 251 | 3.5% |
| Travel and Lodging | $10,069 | 113 | 2.3% |
| Honoraria | $1,183 | 1 | 0.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $350.00 | 1 | 0.1% |
| Education | $30.66 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $150,866 | 180 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $129,182 | 132 | $0 (2019) |
| Lilly USA, LLC | $114,459 | 136 | $0 (2024) |
| Merck Sharp & Dohme LLC | $23,472 | 25 | $0 (2023) |
| Daxor Corporation | $6,933 | 5 | $0 (2024) |
| Abbott Laboratories | $2,395 | 25 | $0 (2024) |
| BIOTRONIK INC. | $1,533 | 2 | $0 (2021) |
| Boston Scientific Corporation | $1,396 | 17 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,098 | 8 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,023 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,144 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,919) |
| 2023 | $42,256 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,161) |
| 2022 | $40,703 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27,119) |
| 2021 | $58,301 | 64 | Lilly USA, LLC ($41,325) |
| 2020 | $35,099 | 43 | Lilly USA, LLC ($29,808) |
| 2019 | $73,300 | 103 | Boehringer Ingelheim Pharmaceuticals, Inc. ($31,628) |
| 2018 | $27,827 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,865) |
| 2017 | $127,655 | 203 | Novartis Pharmaceuticals Corporation ($97,002) |
All Payment Transactions
593 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $80.45 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $112.76 | General |
| Category: Heart Failure | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $83.45 | General |
| Category: Heart Failure | ||||||
| 10/17/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $60.54 | General |
| Category: Heart Failure | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Obesity | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $118.55 | General |
| Category: Heart Failure | ||||||
| 09/16/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $148.18 | General |
| Category: Heart Failure | ||||||
| 07/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: DIABETES | ||||||
| 07/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $95.11 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $106.80 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: DIABETES | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $71.42 | General |
| Category: DIABETES | ||||||
| 05/23/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $118.12 | General |
| Category: Heart Failure | ||||||
| 05/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $96.88 | General |
| Category: DIABETES | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $138.60 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $124.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $52.47 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,758 | 2,371 | $441,815 | $158,675 |
| 2022 | 22 | 1,809 | 2,514 | $443,280 | $163,581 |
| 2021 | 18 | 1,864 | 2,614 | $432,615 | $170,020 |
| 2020 | 26 | 1,884 | 2,573 | $470,578 | $180,141 |
Total Patients
7,315
Total Services
10,072
Medicare Billing
$672,417
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 404 | 501 | $117,735 | $46,574 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 114 | 142 | $45,840 | $18,790 | 41.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 72 | 186 | $39,160 | $17,859 | 45.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 146 | $21,630 | $9,406 | 43.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 49 | 106 | $22,550 | $9,271 | 41.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 153 | 157 | $29,045 | $8,005 | 27.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 503 | 670 | $43,550 | $7,435 | 17.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 51 | $21,195 | $7,243 | 34.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 39 | $20,470 | $6,825 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 91 | $14,105 | $5,746 | 40.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 13 | 35 | $9,625 | $4,403 | 45.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $11,340 | $3,931 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $11,090 | $3,289 | 29.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 20 | 20 | $6,875 | $2,984 | 43.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $8,785 | $2,873 | 32.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 18 | 18 | $4,840 | $1,859 | 38.4% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 21 | 21 | $4,305 | $1,053 | 24.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 25 | 25 | $1,875 | $456.96 | 24.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 20 | 20 | $2,200 | $257.94 | 11.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 23 | 23 | $4,600 | $227.26 | 4.9% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $700.00 | $143.50 | 20.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 20 | 20 | $300.00 | $44.46 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 410 | 524 | $123,140 | $48,984 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 134 | 192 | $57,600 | $27,139 | 47.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 81 | 249 | $34,860 | $14,578 | 41.8% |
About Dr. Christopher Droogan, DO
Dr. Christopher Droogan, DO is a Cardiovascular Disease healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174528129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Droogan, DO has received a total of $434,285 in payments from pharmaceutical and medical device companies, with $29,144 received in 2024. These payments were reported across 593 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($378,583).
As a Medicare-enrolled provider, Droogan has provided services to 7,315 Medicare beneficiaries, totaling 10,072 services with total Medicare billing of $672,417. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Wynnewood, PA
- Active Since 06/16/2005
- Last Updated 04/19/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1174528129
Products in Payments
- JARDIANCE (Drug) $206,035
- ENTRESTO (Drug) $129,182
- TRULICITY (Drug) $47,500
- VERQUVO (Drug) $23,472
- PRADAXA (Drug) $11,789
- BVA-100 (Device) $6,933
- WATCHMAN (Device) $1,118
- FARXIGA (Drug) $1,022
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $883.53
- Circulatory Support (Device) $445.67
- CardioMEMS HF System (Device) $434.54
- Impella (Device) $385.05
- HeartMate 3 Left Ventricular Dev (Device) $295.95
- XARELTO (Drug) $234.10
- CARDIOMEMS (Device) $168.90
- HeartMate (Device) $162.42
- GENERAL - THERAPIES (Device) $149.42
- OPTIMIZER (Device) $143.01
- GIAPREZA (Drug) $138.60
- UPTRAVI (Drug) $137.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Wynnewood
Steven Domsky, Md, MD
Cardiovascular Disease — Payments: $154,429
Cardiovascular Disease $154,429
Thomas Phiambolis, Md, MD
Cardiovascular Disease — Payments: $63,851
Cardiovascular Disease $63,851
Irving Herling, Md, MD
Cardiovascular Disease — Payments: $22,143
Cardiovascular Disease $22,143
Jeffrey Wuhl, Md, MD
Cardiovascular Disease — Payments: $17,636
Cardiovascular Disease $17,636
Steven Liskov
Cardiovascular Disease — Payments: $15,721
Cardiovascular Disease $15,721
Sandra Abramson, Md, MD
Cardiovascular Disease — Payments: $11,147
Cardiovascular Disease $11,147